Fundraising FoxImmunespec
1 known investors
Find your way into Immunespec
Sign up to see every warm intro you have to Immunespec
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Immunespec team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImmuneSpecs uses immunopeptidomics (MAPPs) technology to identify peptides presented by MHC molecules, enabling precise mapping of T cell epitopes in biotherapeutics and validation of immunotherapy targets. The company serves biopharmaceutical organizations seeking advanced antigen presentation analysis.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Immunespec do?
- ImmuneSpecs uses immunopeptidomics (MAPPs) technology to identify peptides presented by MHC molecules, enabling precise mapping of T cell epitopes in biotherapeutics and validation of immunotherapy targets. The company serves biopharmaceutical organizations seeking advanced antigen presentation analysis.
- Who founded Immunespec?
- Immunespec was founded by Elise Pepermans, Kurt Boonen.
- Who are Immunespec's investors?
- Immunespec's investors include Heran Partners.